International Federation of Gynecology and Obstetrics

Women's health breast screenings using MRI are not being attended by many high-risk females.

This is the finding of a new study published in the journal Academic Radiology and conducted by a team at the University of Colorado in the US, who analysed data on 64,659 patients.

Previous women's health research has shown surgical breast biopsies are conducted too often, but a new study has suggested doctors are not overusing this technique.

Women's health could be improved with vaccination in early stages of breast cancer, as a study has found immunisation can eradicate a significant proportion of tumours.

A researcher at Tel Aviv University in Israel is to test his theory that the survival rates of patients with tumours could be improved with drugs to combat stress after operations, which could be a step forward in the treatment of gynaecological cancers.

A team of researchers in Ireland has produced a vaccine to treat preclinical tumours, which could be of interest to those working with patients with gynaecological cancers.

Professor of experimental immunology at Trinity College Dublin Professor Kingston Mills led scientists to the discovery of a way to manipulate the body's defence system to attack malignant growths.

Young female breast cancer survivors are more likely to suffer from psychological issues than older patients, women's health research has found.

Taking a different approach to screening for the human papillomavirus (HPV) in developing nations could be required to curb an increase in the prevalence of gynaecological cancers.

The progression of gynaecological cancers and other forms of the disease could be halted by a group of cells in the tumour microenvironment that have remained largely unexplored by researchers.

Women's health may be improved by the development of new breast cancer drugs that target a protein called hepsin.

This is the recommendation of researchers from the University of Helsinki in Finland, who discovered the substance - which is a type of protease - can be behind the spread of this variety of tumour.

Women's health research has shown using two anti-HER2 drugs appears to be better than one in preoperative treatment for nonmetastatic early stage breast cancer.